首页|基于肠道菌群探讨中医从脾胃论治代谢相关脂肪性肝病的理论基础

基于肠道菌群探讨中医从脾胃论治代谢相关脂肪性肝病的理论基础

扫码查看
肠道菌群失调与代谢相关脂肪性肝病(metabolic associated fatty liver disease,MAFLD)的关系密切,调节肠道菌群可以改善MAFLD.从脾胃论治乃中医临床肝病经典治疗方法,临床疗效显著,调节肠道菌群成为从脾胃论治MAFLD新的研究途径.笔者从肠道菌群入手阐述中医从脾胃论治MAFLD的机制,为中医从脾胃论治MAFLD提供现代生物学基础.
To Explore the Theoretical Basis of Spleen and Stomach Treatment of Metabolic Associated Fatty Liver Disease Based on Intestinal Flora
Metabolic associated fatty liver disease(MAFLD)is closely related to intestinal flora disorders,and regulation of intestinal flora can improve MAFLD.Treating MAFLD by spleen and stomach is a classic method of traditional Chinese medicine with remarkable clinical effect.Regulating intestinal flora has become a new research approach for treating MAFLD by spleen and stomach.The authors elaborate the mechanism of spleen and stomach treatment of MAFLD from intestinal flora in order to provide a modern biological basis for spleen and stomach treatment of MAFLD.

metabolic associated fatty liver diseasethe spleen and stomachintestinal flora

张荣、徐强、窦婧、王晓波、王宏峰、王晓忠

展开 >

新疆维吾尔自治区中医医院,新疆乌鲁木齐 830000

代谢相关脂肪性肝病 脾胃 肠道菌群

2024

云南中医学院学报
云南中医学院

云南中医学院学报

影响因子:0.933
ISSN:1000-2723
年,卷(期):2024.47(5)